Personalis, Inc. (PSNL)
USD 3.68
(7.92%)
USD 3.68
(7.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -109.93 Million USD | 16.65% |
| 2022 | -115.53 Million USD | -76.78% |
| 2021 | -65.35 Million USD | -55.06% |
| 2020 | -42.14 Million USD | -88.0% |
| 2019 | -22.41 Million USD | -62.8% |
| 2018 | -13.77 Million USD | 37.87% |
| 2017 | -22.16 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -16.89 Million USD | 10.52% |
| 2024 Q1 | -18.88 Million USD | 5.28% |
| 2023 Q2 | -25.34 Million USD | 2.29% |
| 2023 Q3 | -30.79 Million USD | -21.49% |
| 2023 FY | -96.29 Million USD | 16.65% |
| 2023 Q1 | -25.94 Million USD | 19.15% |
| 2023 Q4 | -19.93 Million USD | 35.27% |
| 2022 Q3 | -27.25 Million USD | 2.23% |
| 2022 FY | -115.53 Million USD | -76.78% |
| 2022 Q1 | -28.3 Million USD | -39.96% |
| 2022 Q4 | -32.08 Million USD | -17.7% |
| 2022 Q2 | -27.88 Million USD | 1.5% |
| 2021 FY | -65.35 Million USD | -55.06% |
| 2021 Q1 | -12.49 Million USD | 6.58% |
| 2021 Q4 | -20.22 Million USD | -14.32% |
| 2021 Q3 | -17.69 Million USD | -18.36% |
| 2021 Q2 | -14.94 Million USD | -19.67% |
| 2020 FY | -42.14 Million USD | -88.0% |
| 2020 Q4 | -13.37 Million USD | -38.51% |
| 2020 Q3 | -9.65 Million USD | -1.63% |
| 2020 Q2 | -9.49 Million USD | 1.32% |
| 2020 Q1 | -9.62 Million USD | -33.75% |
| 2019 Q3 | -5.73 Million USD | -41.1% |
| 2019 Q1 | -5.43 Million USD | -72.52% |
| 2019 Q2 | -4.06 Million USD | 25.23% |
| 2019 Q4 | -7.19 Million USD | -25.58% |
| 2019 FY | -22.41 Million USD | -62.8% |
| 2018 Q1 | -5.16 Million USD | 0.0% |
| 2018 Q3 | -1.75 Million USD | 52.78% |
| 2018 Q4 | -3.14 Million USD | -79.78% |
| 2018 FY | -13.77 Million USD | 37.87% |
| 2018 Q2 | -3.7 Million USD | 28.18% |
| 2017 FY | -22.16 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Biodesix, Inc. | -41.34 Million USD | -165.918% |
| T2 Biosystems, Inc. | -49.66 Million USD | -121.36% |
| Aspira Women's Health Inc. | -18.85 Million USD | -483.153% |
| Castle Biosciences, Inc. | -67.97 Million USD | -61.725% |
| Exact Sciences Corporation | -215.01 Million USD | 48.87% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -1278.814% |
| Illumina, Inc. | -1.06 Billion USD | 89.716% |
| Standard BioTools Inc. | -76.6 Million USD | -43.52% |
| 23andMe Holding Co. | -321.35 Million USD | 65.79% |
| Inotiv, Inc. | -81.46 Million USD | -34.957% |
| Psychemedics Corporation | -2.92 Million USD | -3663.643% |
| RadNet, Inc. | 98.69 Million USD | 211.387% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -2429.59% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 110.02% |
| NeoGenomics, Inc. | -107.73 Million USD | -2.042% |
| Neogen Corporation | 58.66 Million USD | 287.403% |
| Prenetics Global Limited | -52.51 Million USD | -109.348% |
| iSpecimen Inc. | -11.16 Million USD | -884.265% |
| OpGen, Inc. | -15.68 Million USD | -600.744% |
| Neuronetics, Inc. | -30.55 Million USD | -259.809% |
| Precipio, Inc. | -7.62 Million USD | -1342.73% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -969.086% |
| Exagen Inc. | -22.83 Million USD | -381.394% |
| Bionano Genomics, Inc. | -215.24 Million USD | 48.925% |
| CareDx, Inc | -101.9 Million USD | -7.886% |
| Check-Cap Ltd. | -19.28 Million USD | -470.001% |
| Twist Bioscience Corporation | -220.83 Million USD | 50.217% |
| Guardant Health, Inc. | -564.72 Million USD | 80.533% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -4138.761% |
| Natera, Inc. | -446.24 Million USD | 75.364% |
| Fulgent Genetics, Inc. | -72.69 Million USD | -51.229% |
| Sera Prognostics, Inc. | -39.82 Million USD | -176.075% |
| OPKO Health, Inc. | -157.02 Million USD | 29.986% |
| Aclaris Therapeutics, Inc. | -97.35 Million USD | -12.92% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -903.68% |
| Myriad Genetics, Inc. | -123.7 Million USD | 11.127% |
| ICON Public Limited Company | 956.15 Million USD | 111.498% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -2429.59% |
| MDxHealth SA | -27.32 Million USD | -302.298% |
| Prenetics Global Limited | -52.51 Million USD | -109.348% |
| DarioHealth Corp. | -56.18 Million USD | -95.654% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -944.946% |
| Medpace Holdings, Inc. | 336.82 Million USD | 132.639% |
| Mainz Biomed B.V. | -26.64 Million USD | -312.6% |
| Trinity Biotech plc | -27.04 Million USD | -306.493% |
| Sotera Health Company | 276.69 Million USD | 139.732% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -1278.814% |